Skip to main content

Table 2 Characteristics of study patients

From: Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair

 

Tibial nonunion (n = 15)

Femoral nonunion (n = 10)

Total (n = 25)

Sex

 Male

11 (73%)

7 (70%)

18 (72%)

 Female

4 (27%)

3 (30%)

7 (28%)

Age, years

 Mean

52.7

45.1

49.7

 SD

10.1

13.4

11.9

 Min

34

22

22

 Max

68

66

68

Infection

 No

12 (80%)

9 (90%)

21 (84%)

 Previous

3 (20%)

1 (10%)

4 (16%)

Non-smoker

4 (27%)

3 (30%)

7 (28%)

DM

2 (13%)

0 (0%)

2 (8%)

Previous surgery to treat the nonunion, including ABG

1 (7%)

3 (30%)

4 (16%)

Exchange of implants in the current clinical trial

 No exchange of plate

0 (0%)

0 (0%)

0 (0%)

 No exchange of IMN

0 (0%)

0 (0%)

0 (0%)

 Plate addition to plate

3 (20%)

0 (0%)

3 (12%)

 Plate addition to IMN

0 (0%)

2 (20%)

2 (8%)

 Plate to plate

0 (0%)

2 (20%)

2 (8%)

 Plate to IMN

2 (13%)

1 (10%)

3 (12%)

 IMN to plate

1 (7%)

0 (0%)

1 (4%)

 IMN to IMN

4 (27%)

3 (30%)

7 (28%)

 IMN to IMN + plate

2 (13%)

1 (10%)

3 (12%)

 EF to plate

2 (13%)

0 (0%)

2 (8%)

 EF to IMN

0 (0%)

1 (10%)

1 (4%)

 EF to IMN + plate

1 (7%)

0 (0%)

1 (4%)

  1. ABG autologous bone grafting, DM diabetes mellitus, EF external fixator, IMN intramedullary nail, SD standard deviation